Therapeutic Implications of GIPC1 Silencing in Cancer

• Thomas W. Chittenden,

  Affiliations Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America, Department of Statistics, Oxford Centre for Gene Function, University of Oxford, Oxford, United Kingdom

  ⨯
• Jane Pak,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Renee Rubio,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Hailing Cheng,

  Affiliation Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States America

  ⨯
• Kristina Holton,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Niall Prendergast,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Vladimir Glinskii,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Yi Cai,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Aedin Culhane,

  Affiliations Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Stefan Bentink,

  Affiliations Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Mathew Schwede,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Jessica C. Mar,

  Affiliations Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Eleanor A. Howe,

  Affiliations Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America, Department of Statistics, Oxford Centre for Gene Function, University of Oxford, Oxford, United Kingdom

  ⨯
• Martin Aryee,

  Affiliation Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University and Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States America

  ⨯
• Razvan Sultana,

  Affiliation Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America

  ⨯
• Anthony A. Lanahan,

  Affiliation Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States America

  ⨯
• Jennifer M. Taylor,

  Affiliation CSIRO Plant Industry, Canberra, Australia

  ⨯
• Chris Holmes,

  Affiliations Department of Statistics, Oxford Centre for Gene Function, University of Oxford, Oxford, United Kingdom, Mammalian Genetics Unit, Medical Research Council Harwell, Oxfordshire, United Kingdom

  ⨯
• William C. Hahn,

  Affiliations Department of Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States America

  ⨯
• Jean J. Zhao,

  Affiliation Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States America

  ⨯
• J. Dirk Iglehart,

  Affiliation Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States America

  ⨯
•  [ ... ],
• John Quackenbush

  * E-mail: johnq@jimmy.harvard.edu

  Affiliations Functional Genomics and Computational Biology Group, Department of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States America, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• [ view all ]
• [ view less ]